Copyright
©The Author(s) 2020.
World J Clin Oncol. Sep 24, 2020; 11(9): 747-760
Published online Sep 24, 2020. doi: 10.5306/wjco.v11.i9.747
Published online Sep 24, 2020. doi: 10.5306/wjco.v11.i9.747
Table 4 Recurrence pattern between chemotherapy, chemoradiation therapy, and chemotherapy plus chemoradiation therapy groups, n (%)
| Recurrence site | Group A, n = 65 | Group B, n = 62 | Group C, n = 208 | P value |
| Remnant pancreas | 2 (3.1) | 2 (3.2) | 8 (3.8) | 0.945 |
| Operation bed | 16 (24.6) | 17 (27.4) | 47 (22.5) | 0.728 |
| Liver | 24 (36.9) | 13 (21.0) | 53 (25.4) | 0.089 |
| Peritoneum | 9 (13.8) | 3 (4.8) | 29 (13.9) | 0.144 |
| Lung | 8 (12.3) | 4 (6.5) | 19 (9.1) | 0.521 |
| Lymph node | 3 (4.6) | 8 (12.9) | 17 (8.1) | 0.238 |
| Local only | 9 (19.1) | 12 (36.4) | 29 (22.0) | 0.158 |
| Distant | 38 (80.9) | 21 (63.6) | 100 (75.8) | 0.205 |
| Multiple site | 13 (20.0) | 11 (17.7) | 36 (17.3) | 0.884 |
- Citation: You MS, Ryu JK, Huh G, Chun JW, Paik WH, Lee SH, Kim YT. Comparison of efficacy between adjuvant chemotherapy and chemoradiation therapy for pancreatic cancer: AJCC stage-based approach. World J Clin Oncol 2020; 11(9): 747-760
- URL: https://www.wjgnet.com/2218-4333/full/v11/i9/747.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i9.747